What is the role of Enhanced Recovery After Surgery (ERAS) protocols in major abdominal surgeries?

Enhanced Recovery After Surgery (ERAS) Protocols in Major Abdominal Surgery

ERAS protocols should be implemented as standard of care for all major abdominal surgeries, as they reduce postoperative complications by approximately 50% in colorectal surgery and significantly decrease hospital length of stay by 1.88-2.5 days across all major abdominal procedures without increasing readmission rates or mortality. 1, 2

Core Mechanism and Evidence Base

ERAS represents a multimodal, multidisciplinary, evidence-based approach to perioperative care that fundamentally reduces the surgical stress response and systemic inflammatory reaction. 1 The breakthrough came in 2010 when meta-analysis demonstrated that ERAS reduced complications by 50% after colorectal surgery, sparking widespread adoption across surgical specialties. 1

The primary mechanism behind improved outcomes is the marked reduction in stress reactions to surgery, as many ERAS elements specifically target this physiological response. 1 This is particularly important because the magnitude of the postoperative systemic inflammatory response directly corresponds to surgical trauma severity and correlates with poorer surgical outcomes. 1

Clinical Outcomes Across Major Abdominal Surgery

Morbidity and Mortality Benefits

• Overall complications are reduced by 29-38% (RR 0.71,95% CI: 0.59-0.87) across major abdominal surgeries. 2
• 30-day complications specifically decrease by 27% (RR 0.73,95% CI: 0.56-0.94). 2
• Pulmonary complications are reduced by 52% (RR 0.48,95% CI: 0.28-0.82), a critical outcome given that pulmonary complications can reach 30% in traditional care. 3, 4
• No increase in 30-day mortality (RR 1.04,95% CI: 0.81-1.35), confirming safety. 2

Hospital Stay and Recovery

• Hospital length of stay is reduced by 1.88-2.5 days across all major abdominal procedures (95% CI: 0.95-2.81 days). 2, 5
• Postoperative hospital stay specifically decreases by 2.83 days (95% CI: 2.10-3.55 days). 2
• Time to first flatus is reduced by 0.8 days (95% CI: 0.4-1.1 days), indicating faster return of bowel function. 2, 5
• Cost reduction averages $5,109 per patient (95% CI: $4,365-$5,852). 5

Readmission Rates

• No significant increase in 30-day readmissions (RR 1.04,95% CI: 0.81-1.35), though one gastric cancer study showed increased readmissions (RR 2.43). 2, 3
• When readmission timeframe is unspecified, ERAS shows protective effect (RR 0.61,95% CI: 0.41-0.93). 2

Essential ERAS Protocol Elements

The typical ERAS protocol includes approximately 11-12 elements of 16 possible components, with compliance averaging 74.7% when reported. 2 The most consistently implemented and evidence-based elements include:

Preoperative Phase

• Patient education and counseling about ERAS expectations, early nutrition, and mobilization. 1
• Avoid prolonged fasting: Clear fluids including carbohydrate drinks up to 2 hours before surgery, solids up to 6 hours. 6
• Carbohydrate loading (12.5% maltodextrin, 800ml evening before, 400ml 2-3 hours preoperatively) attenuates catabolic response and reduces insulin resistance. 6
• No routine mechanical bowel preparation in colorectal surgery, as it does not improve outcomes. 7

Intraoperative Phase

• Multimodal opioid-sparing analgesia to reduce opioid-related complications. 1
• Goal-directed fluid therapy with maintenance of low central venous pressure during liver surgery induces faster recovery. 4
• Maintain normothermia throughout the procedure. 1
• Minimize use of drains and nasogastric tubes. 1
• Small incisions/minimally invasive approaches when feasible, as laparoscopic surgery combined with ERAS shows synergistic benefits. 1, 8

Postoperative Phase

• Early nasogastric tube removal reduces morbidity, bowel recovery time, and hospital stay. 7
• Early oral nutrition on postoperative day 0-1. 1
• Early mobilization beginning day of surgery or postoperative day 1. 1
• Multimodal prevention of postoperative nausea and vomiting. 1
• Oral laxatives for quicker bowel recovery. 4
• Early removal of lines and drains when clinically appropriate. 1

Special Populations and Considerations

Vulnerable Patients

ERAS benefits extend to high-risk populations including frail and older adults, patients with diabetes, and those with undernutrition, facilitating optimal metabolic and nutritional care. 1 This is particularly important as ERAS reduces the impact of traditional risk factors. 1

Compliance and Outcomes

Better protocol compliance directly correlates with superior outcomes. In colorectal surgery, higher compliance results in shorter stays, fewer readmissions, fewer complications, and improved 5-year survival. 1 Poor compliance can overshadow the benefits of minimally invasive surgery and may negate the protective effects against comorbidities. 1

Emergency Surgery

ERAS protocols are effective even in emergency abdominal surgery settings, showing:

• Reduced time to first flatus by 1.40 days (P < 0.00001). 9
• Shorter hospital stay by 3.09 days (P < 0.00001). 9
• Lower total complications (OR 0.50, P < 0.00001) and major complications (OR 0.60, P = 0.0008). 9
• No increase in readmission or reoperation rates. 9

Monitoring and Quality Indicators

C-reactive protein (CRP) on postoperative day 3 serves as a useful biomarker for predicting complications:

• CRP <75 mg/L indicates safe discharge criterion. 1
• CRP >215 mg/L predicts major complications. 1
• CRP <159 mg/L makes infectious complications very unlikely. 1

Implementation Considerations

Global Applicability

The ERAS Society implementation program has proven effective across all major continents and different socioeconomic environments. 1 In low- and middle-income countries, ERAS protocols show:

• 37% reduction in postoperative morbidity (RR 0.63,95% CI: 0.55-0.66). 10
• Significant reduction in hospital stay (SMD -0.68,95% CI: -0.90 to -0.47). 10
• No increase in mortality or readmissions. 10

Economic Impact

ERAS economics are positive regardless of healthcare financing system, with marked reduction in complications and resource utilization through faster recovery and shorter stays. 1 The cost reduction averages over $5,000 per patient. 5

Critical Pitfalls to Avoid

• Do not implement partial protocols: The multimodal nature is essential; cherry-picking elements reduces effectiveness. 1
• Do not neglect compliance monitoring: Track adherence to protocol elements, as compliance directly impacts outcomes. 1, 2
• Do not exclude high-risk patients: ERAS benefits extend to vulnerable populations and should not be withheld. 1
• Do not use routine nasogastric tubes or drains: These should be omitted unless specifically indicated. 4, 7
• Do not continue overnight fasting: This outdated practice increases surgical stress. 6

Specialty-Specific Evidence

Beyond colorectal surgery, ERAS has been validated in:

• Liver surgery: Reduced complications and length of stay with normal liver parenchyma. 4
• Cystectomy: Lower complication rates (RR 0.85), shorter stay, faster bowel function return. 11, 7
• Gastric cancer surgery: Reduced length of stay by 1.78 days, lower pulmonary infections. 3
• Laparoscopic procedures: Synergistic benefits with 2.37-day shorter stay when combined with ERAS. 8